VolitionRX Limited (NYSEAMERICAN:VNRX – Get Free Report) shares crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $0.28 and traded as low as $0.2203. VolitionRX shares last traded at $0.2241, with a volume of 2,703,582 shares traded.
VolitionRX Stock Performance
The company has a market capitalization of $30.09 million, a PE ratio of -0.97 and a beta of 1.29. The company’s 50-day moving average is $0.28 and its 200 day moving average is $0.45.
About VolitionRX
VolitionRX, traded as VNRX on the NYSE American exchange, is a pioneering life sciences company focused on the development and commercialization of minimally invasive diagnostic tests for the early detection of cancer and other diseases. Utilizing proprietary technology to analyze circulating nucleosomes in blood samples, the company’s platform identifies disease-specific epigenetic and biochemical signatures. By offering blood-based screening solutions, VolitionRX aims to deliver alternatives to invasive, costly and time-consuming procedures, potentially improving patient outcomes through earlier diagnosis.
The company’s flagship product suite, branded as Nu.Q, comprises assays designed to detect biomarkers associated with a range of malignancies, including colorectal, lung and pancreatic cancers, as well as other systemic conditions.
Featured Articles
- Five stocks we like better than VolitionRX
- Is THIS the Next Big Money Rush?
- Wall Street Legend Names #1 Stock of 2026 Live On-Camera
- Washington knows what’s coming. Do you?
- ISPC: From Small Cap to Life Sciences Market Disruptor!
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for VolitionRX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VolitionRX and related companies with MarketBeat.com's FREE daily email newsletter.
